| Nov 15 |
BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 14 |
BioRestorative Therapies GAAP EPS of -$0.13
|
| Nov 14 |
BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
BioRestorative Therapies GAAP EPS of -$0.13 beats by $0.30
|
| Nov 13 |
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
|
| Nov 12 |
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 6 |
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
|
| Nov 5 |
BioRestorative Therapies rises on expanded tissue license from NY state health department
|
| Nov 5 |
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
|
